113 related articles for article (PubMed ID: 22448531)
1. Vesiculobullous skin reaction temporally related to firocoxib treatment in a white rhinoceros (Ceratotherium simum).
Stringer EM; De Voe RS; Linder K; Troan B; McCalla-Martin A; Loomis MR
J Zoo Wildl Med; 2012 Mar; 43(1):186-9. PubMed ID: 22448531
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C
Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.
Orsini JA; Ryan WG; Carithers DS; Boston RC
Am J Vet Res; 2012 May; 73(5):664-71. PubMed ID: 22533398
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
Autefage A; Palissier FM; Asimus E; Pepin-Richard C
Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297
[TBL] [Abstract][Full Text] [Related]
5. Tolerance of firocoxib in dogs with osteoarthritis during 90 days.
Lecoindre O; Pepin-Richard C
J Vet Pharmacol Ther; 2011 Apr; 34(2):190-2. PubMed ID: 21395612
[No Abstract] [Full Text] [Related]
6. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
Doucet MY; Bertone AL; Hendrickson D; Hughes F; Macallister C; McClure S; Reinemeyer C; Rossier Y; Sifferman R; Vrins AA; White G; Kunkle B; Alva R; Romano D; Hanson PD
J Am Vet Med Assoc; 2008 Jan; 232(1):91-7. PubMed ID: 18167116
[TBL] [Abstract][Full Text] [Related]
7. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
Ryan WG; Moldave K; Carithers D
Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494
[TBL] [Abstract][Full Text] [Related]
8. The effects of firocoxib (Previcox) in geriatric dogs over a period of 90 days.
Joubert KE
J S Afr Vet Assoc; 2009 Sep; 80(3):179-84. PubMed ID: 20169752
[TBL] [Abstract][Full Text] [Related]
9. CLINICAL MANAGEMENT OF BILATERAL CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HIND FEET PADS IN A SOUTHERN WHITE RHINOCEROS (CERATOTHERIUM SIMUM SIMUM).
Greunz EM; Simon M; Lemberger K; Galateanu G; Hermes R; Leclerc A
J Zoo Wildl Med; 2016 Jun; 47(2):645-9. PubMed ID: 27468043
[TBL] [Abstract][Full Text] [Related]
10. Switching NSAIDs in practice: insights from the Previcox (firocoxib) Experience Trial.
Ryan WG; Moldave K; Carithers D
Vet Ther; 2007; 8(4):263-71. PubMed ID: 18183545
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous adverse drug reaction in a dog following firocoxib treatment.
Geum M; Ko HY; Na YJ; Kim HJ
Vet Med Sci; 2021 Sep; 7(5):1504-1508. PubMed ID: 34021731
[TBL] [Abstract][Full Text] [Related]
12. The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.
Back W; MacAllister CG; van Heel MC; Pollmeier M; Hanson PD
Equine Vet J; 2009 Mar; 41(3):309-12. PubMed ID: 19469242
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and safety of firocoxib after oral administration of repeated consecutive doses to neonatal foals.
Hovanessian N; Davis JL; McKenzie HC; Hodgson JL; Hodgson DR; Crisman MV
J Vet Pharmacol Ther; 2014 Jun; 37(3):243-51. PubMed ID: 24749691
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.
de Salazar Alcalá AG; Gioda L; Dehman A; Beugnet F
BMC Vet Res; 2019 Aug; 15(1):309. PubMed ID: 31464629
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses.
Kivett L; Taintor J; Wright J
J Vet Pharmacol Ther; 2014 Aug; 37(4):413-6. PubMed ID: 24354928
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
Pollmeier M; Toulemonde C; Fleishman C; Hanson PD
Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs.
Hazewinkel HA; van den Brom WE; Theyse LF; Pollmeier M; Hanson PD
Res Vet Sci; 2008 Feb; 84(1):74-9. PubMed ID: 17408711
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis.
Cathcart CJ; Johnston SA; Reynolds LR; Al-Nadaf S; Budsberg SC
Am J Vet Res; 2012 Jan; 73(1):19-26. PubMed ID: 22204284
[TBL] [Abstract][Full Text] [Related]
19. Phenylbutazone pharmacokinetics in southern white rhinoceros (Ceratotherium simum simum) after oral administration.
Houck EL; Papich MG; Delk KW
J Vet Pharmacol Ther; 2022 Mar; 45(2):196-202. PubMed ID: 34894412
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of a patent urachus in a white rhinoceros calf (Ceratotherium simum simum).
Langan J; Ramsay E; Schumacher J; Chism T; Adair S
J Zoo Wildl Med; 2001 Mar; 32(1):118-22. PubMed ID: 12790407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]